• Худойбердиева Г.С., Болтаев А.И., Мусурмонов А.М., Маматалиев А.Р.
  Самаркандский государственный медицинский университет, Республика Узбекистан, г. Самарканд

Abstract

Предменструальный синдром (ПМС)- является патологическим  симптомокомплексом, который значительно снижает качество жизни женщины. Этиология и патогенез до сих пор не изучены в достаточной степени, но диагноз, лечение и профилактика должны быть соблюдены. Лечение ПМС должно быть дифференцированным с учетом общего и репродуктивного здоровья женщины, сопутствующих заболеваний, степени серьезности ПМС, переносимости терапии и т.д.

Keywords

Предменструальный синдром, качество жизни, Витекс Агнус-каст, Мастодинон, Циклодинон.

Literature

1. Prilepskaya VN, Ledina AV, Tagiyeva AV, Revazova FSVitex agnus castus: Successful treatment of moderate tosevere premenstrual syndrome Maturitas, 2006, 55(Supplement 1): 55-63

2.  Aganezova N.V. Premenstrual syndrome: biological and psychosocial predictors of pathogenesis,clinical picture, rationale for complex therapy Doctoral dissertation, 2011, 372 Ledina AV

3.  Premenstrual syndrome: epidemiology, clinic, diagnosis and treatment Abstract of doctoral dissertation, 2014 Management of premenstrual syndrome

4. Green-top Guideline No 48, BJOG, 2016 DOI: 10 1111 / 1471- 0528 14260 November 2016, Royal College of Obstetricians and Gynaecologists NICE

5. Zamani M, Neghab N, Torabian S Therapeuticeffect of Vitex agnus castus in patients with premenstrual syndrome Acta MedIran, 2012, 50: 101–6

6. Prilepskaya V N, Mezhevitinova E A,Sasunova R A , Ivanova EV , Letunovskaya A B , Nabieva K R Results of clinical use of the drugcontaining drospirenone, in women with severe PMSobstetrics and gynecology, 2012, 2: 81-85

7. Mahmoud Rafieian-Kopaei and Mino MovahediSystematic Review of Premenstrual, Postmenstrualand Infertility Disorders of Vitex Agnus CastusElectronic physician, 2017 January, 9 (Issue 1):3685-3689

8. Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei MOxidative stress and Parkinson's disease: New hopes intreatment with herbal antioxidants Curr Pharm Des,2016, 22 (2): 238–46

9. Miraj S, Rafieian-Kopaei, Kiani S Melissa officinalis L: A Review Study With an Antioxidant Prospective J EvidBased Complementary Altern Med, 2016

10. Baharvand-Ahmadi B, Bahmani M, Tajeddini P,Rafieian-Kopaei M, Naghdi N An ethnobotanicalstudy of medicinal plants administered for thetreatment of hypertension J Renal Inj Prev, 2016, 5(3): 123–8

11. Rouhi-Boroujeni H, Rouhi-Boroujeni H, Gharipour M,Mohammadizadeh F, Ahmadi S, Rafieian-Kopaei MSystematic review on safety and drug interaction of herbal therapy in hyperlipidemia: a guide for internist Acta biomed, 2015, 86 (2): 130–6

12. Khalilzadeh E,Vafaei Saiah G, Hasannejad H,Ghaderi A, Ghaderi S, Hamidian G, et alAntinociceptive effects, acute toxicity and chemicalcomposition of Vitex agnus-castus essential oil. Avicenna J Phytomed, 2015, 5(3): 218–30.

13. He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S, et al. Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multicenter place bo controlled study in China. Maturitas,2009, 63(1): 99–103.

14. Jang SH, Kim DI, Choi MS. Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review. BMC Complement AlternMed, 2014, 14: 11.

15. Weisz G, Knaapen L. Diagnosing and treating premenstrual syndrome in five western nations. Soc SciMed, 2009, 68(8): 1498–505.

16. Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol,2003, 18(3): 191–5.

17. Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X.Evaluating therapeutic effect in symptoms of moderate- to - severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust N Z J Obstet Gynaecol, 2010, 50(2): 189–93.

18. Kelderhouse K1, Taylor JS. A review of treatmentand management modalities for premenstrual dysphoricdisorder. Nurs Womens Health, 2013 Aug-Sep,17(4): 294-305.

19. Birgit M. Dietz, Atieh Hajirahimkhan, Tareisha L.Dunlap, and Judy L. Botanicals and Their BioactivePhytochemicals for Women’s Health. Pharmacol Rev,2016 Oct, 68(4): 1026–1073.

20. Rafieian-Kopaei M, Saki K, Bahmani M, GhafourianS, Sadeghifard N, Taherikalani M. ListeriosisPhytotherapy: A Review Study on the Effectivenessof Iranian Medicinal Plants in Treatment of Listeriosis. J Evid Based Complementary Altern Med,2015

21. M. Diana van Die, Henry G. Burger, Helena J. Teede, Kerry M. Bone. Vitex agnus-castus Extracts forFemale Reproductive Disorders: A Systematic Review of Clinical Trials. Women’s Health. Planta Med,2013, 79(07): 562-575.

22. Bahmani M, Sarrafchi A, Shirzad H, Rafieian-KopaeiM. Autism: Pathophysiology and Promising HerbalRemedies. Curr Pharm Des, 2016, 22(3): 277–85.

23. Ambrosini A, Di Lorenzo C, Coppola G, Pierelli F. Useof Vitex agnus-castus in migrainous women withpremenstrual syndrome: an open-label clinicalobservation. Acta Neurol Psychiatr Belg, 2013, 113(1):25–9.

24. Webster DE, He Y, Chen SN, Pauli GF, FarnsworthNR, Wang ZJ. Opioidergic mechanisms underlyingthe actions of Vitex agnus-castus L. Biochem pharmacol,2011, 81(1): 170–7.

25. van Die MD, Bone KM, Burger HG, Reece JE, TeedeHJ. Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from as ub population analysis. J Altern Complement Med,2009, 15(9): 1045–8.

26. Royal College of Obstetricians and Gynaecologists/NAPS Guidelines on Guidelines on Premenstrual Syndrom. 01/12/2016.

27. Marjoribanks J1, Brown J, O’Brien PM, Wyatt K.Selective serotonin reuptake inhibitors for premenstrualsyndrome. Cochrane Database Syst Rev, 2013Jun 7, 6: CD001396.

28. Upchurch DM, Chyu L, Greendale GA, Utts J, Bair YA,Zhang G, Gold EB. Complementary and alternativemedicine use among American women: findingsfrom The National Health Interview Survey, 2002. JWomenʼs Health (Larchmt), 2007, 16: 102-113.

29. Zamani M, Neghab N, Torabian S. Therapeutic effectof Vitex agnus castus in patients with premenstrualsyndrome. Acta Med Iran, 2012, 50(2): 101–6.

30. Ledina А.V., Prilepskaya V.N., Droopnene-containing contraceptives: preventive and curative aspects of the use. Gynecology, 2015, 17(1): 25-29.

31. Lauritzen C, Reuter HD, Repges R, Bohnert KJ,Schmidt U. Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, doubleblind study versus pyridoxine. Phytomedicine, 1997,4(3): 183–9.

32. Andrade C. Premenstrual dysphoric disorder:General overview, treatment strategies, and focuson sertraline for symptom-onset dosing. Indian JPsychiatry, 2016 Jul-Sep, 58(3): 329- 331.

33. Ryu A, Kim TH. Premenstrual syndrome: A minireview. Maturitas, 2015 Dec, 82(4): 436-40.